J. Goldman & CO LP Karyopharm Therapeutics Inc. Transaction History

J. Goldman & CO LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $478,505 - $759,733	-419,742 Reduced 77.77%	120,000 $160,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $966,138 - $2.48 Million	539,742 New	539,742 $966,000
Q1 2022 May 16, 2022	SELL	$5.91 - $14.38 $1.62 Million - $3.94 Million	-274,243 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $1.13 Million - $1.86 Million	216,517 Added 375.08%	274,243 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $4.22 Million - $10.1 Million	-947,236 Reduced 94.26%	57,726 $336,000
Q2 2021 Aug 16, 2021	SELL	$8.11 - $11.11 $2.65 Million - $3.62 Million	-326,142 Reduced 24.5%	1,004,962 $10.4 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $10.5 Million - $18.9 Million	1,069,375 Added 408.58%	1,331,104 $14 Million
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $1.13 Million - $1.37 Million	79,825 Added 43.88%	261,729 $4.05 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $1.14 Million - $1.59 Million	80,655 Added 79.66%	181,904 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $1.21 Million - $1.84 Million	72,959 Added 257.9%	101,249 $1.92 Million
Q1 2020 May 15, 2020	SELL	$14.38 - $27.72 $75,423 - $145,391	-5,245 Reduced 15.64%	28,290 $543,000
Q4 2019 Feb 14, 2020	SELL	$9.23 - $19.67 $2.55 Million - $5.43 Million	-276,044 Reduced 89.17%	33,535 $643,000
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $1.75 Million - $3.67 Million	309,579 New	309,579 $2.98 Million

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.